| Companies sponsors |
Pierre Fabre (vibegron) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Professional groups |
British Society of Urogynaecology |
| |
Royal College of Physicians |
| Comparator companies |
Aristo Pharma (fesoterodine) (CAU not signed - not participating) |
| |
Aspire Pharma (darifenacin, fesoterodine, solifenacin, tolterodine)(CAU not signed - not participating) |
| |
Astellas Pharma (mirabegron, solifenacin)(CAU signed - participating) |
| |
Aurobindo Pharma – Milpharm (solifenacin)(CAU not signed - not participating) |
| |
Brillpharma (oxybutynin)(CAU not signed - not participating) |
| |
Brown & Burk (solifenacin)(CAU not signed - not participating) |
| |
Celix Pharma (fesoterodine, solifenacin)(CAU not signed - not participating) |
| |
Dr. Reddy's Laboratories (fesoterodine)(CAU not signed - not participating) |
| |
Genus Pharmaceuticals (fesoterodine, solifenacin)(CAU not signed - not participating) |
| |
Ennogen Healthcare (propiverine)(CAU not signed - not participating) |
| |
Glenmark Pharmaceuticals (solifenacin, trospium)(CAU not signed - not participating) |
| |
Krka (solifenacin)(CAU not signed - not participating) |
| |
Medical Valley Invest (fesoterodine)(CAU not signed - not participating) |
| |
MSN Laboratories (solifenacin)(CAU not signed - not participating) |
| |
Neon Healthcare (oxybutynin)(CAU not signed - not participating) |
| |
Northumbria Pharma (tolterodine)(CAU not signed - not participating) |
| |
Pfizer (fesoterodine)(CAU not signed - not participating) |
| |
Ranbaxy, a Sun Pharmaceutical Company (solifenacin)(CAU not signed - not participating) |
| |
Roma Pharmaceuticals (oxybutynin)(CAU not signed - not participating) |
| |
Sandoz (solifenacin, tolterodine)(CAU not signed - not participating) |
| |
Strides Pharma (oxybutynin)(CAU not signed - not participating) |
| |
SyriMed (oxybutynin) (CAU not signed - not participating) |
| |
Tillomed Laboratories (oxybutynin, solifenacin)(CAU not signed - not participating) |
| |
Viatris (tolterodine, trospium)(CAU not signed - not participating) |
| |
Zentiva (fesoterodine, oxybutynin, solifenacin, tolterodine)(CAU not signed - not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |